Quiz #4. Test your knowledge on CAR T-cell Products

Axicabtagene ciloleucel is currently indicated for patients with which of the following hematological malignancies?

In which year were CAR T-cell therapies were first approved?

Which CAR T-cell therapy was recently approved for treating adult patients with relapsed or refractory multiple myeloma after four or more prior lines of therapy?

CAR T-cell therapies are only available in the US via a risk evaluation and mitigation strategy (REMS).